BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care

Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

FDA Approves Autolus’s CAR-T Therapy Aucatzyl for Relapsed or Refractory B-ALL in Adults

Home
/
update
/
details

HCGMCC Introduces Vansham Clinic to Promote Hereditary Cancer Awareness and Provide Lifesaving Family Screenings

NextEdge Admin

24 Sep 2024

2 min 24 sec

Vansham Clinic,personalized care,Oncology

HCG Manavata Cancer Centre (HCGMCC), Nashik’s leading cancer specialty hospital, has launched Vansham Clinic to address the rising need for hereditary cancer awareness and early intervention. The clinic offers specialized screening and preventive measures for individuals with a family history of cancer, aiming to bridge the knowledge gap and provide personalized healthcare solutions focused on early detection and tailored treatment plans.

"India is witnessing over 1.4 million new cancer cases annually, with a significant portion driven by genetic predisposition. Individuals with a family history of cancers, like breast, ovarian, and colorectal, face a 5 to 10 percent higher risk. This makes hereditary screening vital for timely intervention," says Dr. Raj Nagarkar, MD & Chief of Surgical Oncology & Robotic Services at HCGMCC. Vansham Clinic aims to raise awareness and offer advanced genetic counseling, targeted screenings, and preventive healthcare to high-risk individuals.

The clinic's specialized team, including genetic counselors and oncologists, ensures personalized care from consultation to follow-up. Appointments are available for both individuals and families, offering a holistic approach that prioritizes education, prevention, and patient empowerment.

In addition to screenings, the clinic provides lifestyle counseling and comprehensive follow-up care, including ongoing surveillance for high-risk individuals. Early detection significantly improves survival rates, with breast cancer survival, for example, reaching up to 99 percent when diagnosed early.

“With Vansham Clinic, our mission is to ensure high-risk individuals receive the preventive care and surveillance they need to stay ahead of cancer,” concludes Dr. Nagarkar.